The transcription factor HEB synergizes with TCR signaling to upregulate Id3, which is required for the maturation of fetal IL-17-producing γδ T cells.
C2S-Scale converts a high-dimensional expression vector into text by rank-ordering genes and emitting the top-K symbols as a gene-name sequence. This representation aligns single-cell data with ...
Department of Cellular and Developmental Biology of Plants, University of Bielefeld, Bielefeld, Germany Algae inhabit diverse environments with highly variable light conditions, making light sensing ...
The Supreme Court on Friday agreed to allow the Trump administration keep frozen billions of dollars in foreign aid that is set to expire next week, the latest turn in a lengthy legal saga over the ...
Cell and gene therapies account for 20% of pipeline Parkinson's therapy bemdaneprocel in Phase 3 trial Pharma success urgently needed, says fund manager FRANKFURT, Sept 25 (Reuters) - Bayer's ...
First investigational allogeneic pluripotent stem cell derived therapy pivotal Phase III clinical trial exPDite-2 with bemdaneprocel started Phase II gene therapy trial REGENERATE-PD with AB-1005 ...
On Wednesday afternoon, Haifan Lin, the director of the Yale Stem Cell Center, discussed his innovative research findings in stem cell gene expression and regulation at Brown’s 2025 Mac V. Edds ...
Translocations are chromosomal “cut and paste” errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but ...
Single cell gene expression studies often rely on single-cell RNA sequencing (scRNA-seq) alone. While scRNA-seq reveals which genes are turned on, it does not capture protein expression or changes to ...
A proof-of-concept study finds that donated insulin-producing cells can be genetically modified to avoid provoking the recipient's immune system. Reading time 3 minutes A new case study offers a ...
The sudden departure of Vinay Prasad, M.D., from the FDA this week again threw the cell and gene therapy field into uncertainty. But this time, the unknown is hitting the industry in a different way ...